Skip to main content
Article thumbnail
Location of Repository

Slc11a1 limits intracellular growth of Salmonella enterica sv. Typhimurium by promoting macrophage immune effector functions and impairing bacterial iron acquisition

By Manfred Nairz, Gernot Fritsche, Marie-Laure V. Crouch, Howard C. Barton, Ferric C. Fang and Günter Weiss


The natural resistance-associated macrophage protein 1, Slc11a1, is a phagolysosomal transporter for protons and divalent ions including iron that confers host protection against diverse intracellular pathogens including Salmonella. We investigated and compared the regulation of iron homeostasis and immune function in RAW264.7 murine phagocytes stably transfected with non-functional Slc11a1 and functional Slc11a1 controls in response to an infection with Salmonella enterica serovar Typhimurium. We report that macrophages lacking functional Slc11a1 displayed an increased expression of transferrin receptor 1, resulting in enhanced acquisition of transferrin-bound iron. In contrast, cellular iron release mediated via ferroportin 1 was significantly lower in Salmonella-infected Slc11a1-negative macrophages in comparison with phagocytes bearing Slc11a1. Lack of Slc11a1 led to intracellular persistence of S.?enterica serovar Typhimurium within macrophages, which was paralleled by a reduced formation of nitric oxide, tumour necrosis factor-alpha and interleukin-6 in Slc11a1-negative macrophages following Salmonella infection, whereas interleukin-10 production was increased. Moreover, Slc11a1-negative phagocytes exhibited higher cellular iron content, resulting in increased iron acquisition by intracellular Salmonella. Our observations indicate a bifunctional role for Slc11a1 within phagocytes. Slc11a restricts iron availability, which first augments pro-inflammatory macrophage effector functions and second concomitantly limits microbial iron access. <br/

Year: 2009
OAI identifier:
Provided by: e-Prints Soton

Suggested articles


  1. (2002). 27 of 50Slc11a1 limits Salmonella iron access 28
  2. (2001). 28 of 50Slc11a1 limits Salmonella iron access 29
  3. (1997). 29 of 50Slc11a1 limits Salmonella iron access 30
  4. (2008). 30 of 50Slc11a1 limits Salmonella iron access 31
  5. (2004). 31 of 50Slc11a1 limits Salmonella iron access 32
  6. (2006). 32 of 50Slc11a1 limits Salmonella iron access 33
  7. (2004). 33 of 50Slc11a1 limits Salmonella iron access 34
  8. (2005). 35 of 50Slc11a1 limits Salmonella iron access 36 Weiss, G.
  9. (2006). A Leishmania amazonensis ZIP family iron transporter is essential for parasite replication within macrophage phagolysosomes. doi
  10. (2005). A nutritive view on the host-pathogen interplay. doi
  11. (2000). Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. I. Effects on microbial killing by activated peritoneal macrophages in vitro. doi
  12. (2000). Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. II. Effects on microbial proliferation and host survival in vivo. doi
  13. (1999). Associations between cellular immune effector function, iron metabolism, and disease activity in patients with chronic hepatitis C virus infection. doi
  14. (2008). Autocrine formation of hepcidin induces iron retention in human monocytes. doi
  15. (2004). Balancing acts: molecular control of mammalian iron metabolism. doi
  16. (2008). Biosynthesis and IroC-dependent export of the siderophore salmochelin are essential for virulence of Salmonella enterica serovar Typhimurium. doi
  17. (2007). Ca2+ channel blockers reverse iron overload by a new mechanism via divalent metal transporter-1. doi
  18. (2003). Cytokine-mediated regulation of iron transport in human monocytic cells. doi
  19. Defective localization of the NADPH phagocyte oxidase to Salmonella-containing phagosomes in tumor necrosis factor p55 receptor-deficient macrophages. doi
  20. (1999). Differential iron transport into phagosomes isolated from the RAW264.7 macrophage cell lines transfected with Nramp1Gly169 or Nramp1Asp169.
  21. (2007). Distinct roles for intra- and extracellular siderophores during Aspergillus fumigatus infection. doi
  22. (2003). Divalent cation transport and susceptibility to infectious and autoimmune disease: continuation of the Ity/Lsh/Bcg/Nramp1/Slc11a1 gene story. doi
  23. (2006). Dysregulated monocyte iron homeostasis and erythropoietin formation in patients with anemia of chronic disease. doi
  24. (2003). Effect of iron treatment on circulating cytokine levels in ESRD patients receiving recombinant human erythropoietin. doi
  25. (1998). Evidence for a link between iron metabolism and Nramp1 gene function in innate resistance against Mycobacterium avium. doi
  26. (2002). Expression and subcellular localization of NRAMP1 in human neutrophil granules. doi
  27. (2004). Expression of epithelial cell iron-related genes upon infection by Neisseria meningitidis. doi
  28. (1999). Extraintestinal dissemination of Salmonella by CD18-expressing phagocytes.
  29. (2000). Gallium disrupts iron metabolism of mycobacteria residing within human macrophages. doi
  30. (1998). Genetic control of immune response to recombinant antigens carried by an attenuated Salmonella typhimurium vaccine strain: Nramp1 influences T-helper subset responses and protection against leishmanial challenge.
  31. (1999). Genetic regulation of macrophage activation: understanding the function of Nramp1 (=Ity/Lsh/Bcg). doi
  32. (1999). High level expression of Nramp1G169 in RAW264.7 cell transfectants: analysis of intracellular iron transport. doi
  33. (2002). Host-pathogen interactions: Host resistance factor Nramp1 up-regulates the expression of Salmonella pathogenicity island-2 virulence genes. doi
  34. (2006). Identification of a tyrosine-based motif (YGSI) in the amino terminus of Nramp1 (Slc11a1) that is important for lysosomal targeting. doi
  35. (2008). Interferongamma limits the availability of iron for intramacrophage Salmonella typhimurium. doi
  36. (2005). Intracellular labile iron pools as direct targets of iron chelators: a fluorescence study of chelator action in living cells. doi
  37. (2002). Intraphagosomal Mycobacterium tuberculosis acquires iron from both extracellular transferrin and intracellular iron pools. Impact of interferon-gamma and hemochromatosis. doi
  38. (2008). Iron acquisition within host cells and the pathogenicity of Leishmania. doi
  39. (2002). Iron and immunity: a double-edged sword. doi
  40. (2001). Iron and its relation to immunity and infectious disease. J Nutr 131, 616S-633S; discussion 633S-635S.
  41. (2003). Iron chelators modulate the fusogenic properties of Salmonella-containing phagosomes. doi
  42. (2008). Iron depletion limits intracellular bacterial growth in macrophages. doi
  43. (2003). Iron loading and erythrophagocytosis increase ferroportin 1 (FPN1) expression in J774 macrophages. doi
  44. (2003). Iron metabolism in the reticuloendothelial system. doi
  45. Iron overload alters innate and T helper cell responses to Candida albicans in mice. doi
  46. (1994). Iron regulates nitric oxide synthase activity by controlling nuclear transcription. doi
  47. (2001). Iron transport into mycobacterium avium-containing phagosomes from an Nramp1(Gly169)-transfected RAW264.7 macrophage cell line.
  48. (2002). Iron transporter Nramp2/DMT-1 is associated with the membrane of phagosomes in macrophages and Sertoli cells. doi
  49. (2003). Iron, manganese, and cobalt transport by Nramp1 (Slc11a1) and Nramp2 (Slc11a2) expressed at the plasma membrane. doi
  50. (2008). Leishmania donovani depletes labile iron pool to exploit iron uptake capacity of macrophage for its intracellular growth. doi
  51. (1998). Localisation of Nramp1 in macrophages: modulation with activation and infection.
  52. (2002). Microbial siderophore-mediated transport. doi
  53. (2000). Modulation of intramacrophage iron metabolism during microbial cell invasion. doi
  54. (2007). Modulation of macrophage iron transport by doi
  55. (2000). Natural resistance to intracellular infections: natural resistance-associated macrophage protein 1 (Nramp1) functions as a pH-dependent manganese transporter at the phagosomal membrane. doi
  56. (1998). Nitric oxide-mediated induction of ferritin synthesis in J774 macrophages by inflammatory cytokines: role of selective iron regulatory protein-2 downregulation.
  57. (2008). Nramp1 drives an accelerated inflammatory response during Salmonella-induced colitis in mice. doi
  58. Nramp1 expression by dendritic cells modulates inflammatory responses during Salmonella Typhimurium infection. doi
  59. (2003). Nramp1 functionality increases inducible nitric oxide synthase transcription via stimulation of IFN regulatory factor 1 expression. doi
  60. (1997). Nramp1 locus encodes a 65 kDa interferon-gamma-inducible protein in murine macrophages.
  61. (2002). Nramp1 modifies the fusion of Salmonella typhimurium-containing vacuoles with cellular endomembranes in macrophages. doi
  62. (2008). Nramp1-functionality increases iNOS expression via repression of IL-10 formation. doi
  63. (1999). Nramp1: a link between intracellular iron transport and innate resistance to intracellular pathogens.
  64. (1998). Patho-ecological implications of microbial acquisition of host iron. doi
  65. (2003). Pathways for the regulation of interferon-gamma-inducible genes by iron in human monocytic cells.
  66. (1989). Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. doi
  67. (2001). Regulatory interactions between iron and nitric oxide metabolism for immune defense against Plasmodium falciparum infection. doi
  68. (1999). Requirement for type 2 NO synthase for IL-12 signaling in innate immunity. doi
  69. (1999). Role of iron in Nramp1-mediated inhibition of mycobacterial growth.
  70. (2003). Severe bacterial infection in transfusion-dependent patients with thalassemia major. doi
  71. (2006). Severe infections in thalassaemic patients: prevalence and predisposing factors. doi
  72. (2001). SLC11A1 (formerly NRAMP1) and disease resistance. doi
  73. (2002). Solute carrier 11a1 (Slc11a1; formerly Nramp1) regulates metabolism and release of iron acquired by phagocytic, but not transferrin-receptor-mediated, iron uptake. doi
  74. (1997). Stabilized expression of mRNA is associated with mycobacterial resistance controlled by Nramp1.
  75. (2008). Systemic iron homeostasis and the iron-responsive element/iron-regulatory protein (IRE/IRP) regulatory network. doi
  76. (1994). T-helper 1-like subset selection in Mycobacterium bovis bacillus Calmette-Guerin-infected resistant and susceptible mice.
  77. (2007). The co-ordinated regulation of iron homeostasis in murine macrophages limits the availability of iron for intracellular Salmonella typhimurium. doi
  78. (2007). The iron chelator deferasirox protects mice from mucormycosis through iron starvation. doi
  79. (1999). The iron transport protein NRAMP2 is an integral membrane glycoprotein that colocalizes with transferrin in recycling endosomes. doi
  80. (2005). The macrophage: a cellular factory at the interphase between iron and immunity for the control of infections. doi
  81. (2006). The NRAMP family of metal-ion transporters. doi
  82. (1999). The Nramp1 protein and its role in resistance to infection and macrophage function. doi
  83. (2006). The pathogen-associated iroA gene cluster mediates bacterial evasion of lipocalin 2. doi
  84. (2000). The putative iron transport system SitABCD encoded on SPI1 is required for full virulence of Salmonella typhimurium. doi
  85. (2003). The role of iron in infections with intracellular bacteria. doi
  86. (2001). The roles of Nramp1 and Tnfa genes in nitric oxide production and their effect on the growth of Salmonella typhimurium in macrophages from Nramp1 congenic and tumor necrosis factor-alpha-/- mice. doi
  87. (2004). The Salmonella enterica serovar typhimurium divalent cation transport systems MntH and SitABCD are essential for virulence in an Nramp1G169 murine typhoid model. doi
  88. (1993). Translational regulation via iron-responsive elements by the nitric oxide/NOsynthase pathway.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.